Lelinski named Walgreens’ corporate VP of market access

July 16, 2013

Walgreens has named Mark Lelinski, formerly an executive with Accenture and AstraZeneca, its corporate vice president, market access.

Walgreens has named Mark Lelinski, formerly an executive with Accenture and AstraZeneca, its corporate vice president, market access. Lelinski, who joined Walgreens in June, will be responsible for contracting and pricing strategies, integration efforts across its pharmacy, health and wellness division, and sales and account management. He will also oversee the company’s managed market strategies.

“Mark is a seasoned leader with an established track record of delivering results, and will help to build upon the excellent work that is being done in our market access group,” said Kermit Crawford, Walgreens president of pharmacy, health and wellness. “His experience in managed market roles both in the U.S. and internationally is the right fit for where Walgreens is headed.”

In his most-recent role at AstraZeneca, Lelinski was responsible for new commercial capabilities across markets in the Unites States, Canada, and Latin America. He headed the pharmaceutical marketing and sales effectiveness practice at Accenture.